Clinical Research Directory
Browse clinical research sites, groups, and studies.
Immunonutrition and Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Summary
The aim of the present project is to evaluate in a randomised, controlled, open-label, two parallel treatment groups pilot study, the efficacy of oral nutritional supplementation with a high-protein-high calorie mixture containing immunonutrients compared to a standard high-calorie-high-protein nutritional blend, in addition to nutritional counseling, in improving tolerance to chemoradiotherapy (CT-RT) in patients with tumours of the head and neck
Official title: Efficacy of Immunonutrition in Improving Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
86
Start Date
2021-03-17
Completion Date
2026-11-15
Last Updated
2025-05-01
Healthy Volunteers
No
Conditions
Interventions
Immunonutrition
In addition to nutritional counseling, patients will receive two servings of an oral high-calorie-high-protein nutritional liquid supplement enriched in immunonutrients (Impact®). The intervention will start 10-15 days before anticancer treatment initiation and will continue until treatment termination or dropout.
Control Nutritional Support
In addition to nutritional counseling, patients will receive two servings of an oral high-calorie-high-protein nutritional liquid supplement. The intervention will start 10-15 days before anticancer treatment initiation and will continue until treatment termination or dropout.
Locations (1)
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy